Novo Nordisk's Alzheimer's Trial Setback: A Closer Look
Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles
A Setback on the Cancer Front: The Unfolding Story of Keytruda and Lenvima
Major Setback: Acadia Pharmaceuticals' Alzheimer's Psychosis Drug Fails Crucial Late-Stage Trial